GE HealthCare's significant acquisition of Nihon Medi-Physics (NMP) from Sumitomo Chemical is set to reshape the medical imaging landscape. This move gives GE HealthCare full ownership of NMP, a company with a rich history and expertise in medical imaging. With a 50% stake since 2004, GE is now poised to leverage NMP's capabilities to drive growth in the molecular imaging market.

Unlock the Potential of Medical Imaging with GE HealthCare's Acquisition

Acquisition Details

GE HealthCare's acquisition of NMP marks a major milestone. Since acquiring Amersham plc in 2004 for $9.5 billion, GE has held a 50% stake in NMP. This acquisition allows NMP to expand its expertise in developing and manufacturing radiopharmaceuticals used in SPECT and PET molecular imaging procedures. Its product line includes GE HealthCare radiopharmaceuticals used in various clinical procedures. NMP also focuses on research and development, including nonclinical and clinical development of radiotracers and theranostics research.

NMP's 13 manufacturing facilities provide a solid foundation for its growth. With this acquisition, GE HealthCare is well-positioned to strengthen its precision care strategy in Asia and expand its footprint in Japan, where its contrast media and medical devices are widely used.

Hiroshi Ueda, executive vice president of Sumitomo Chemical, expressed pride in the 50-year relationship with NMP and its partnership with GE HealthCare. He believes that GE HealthCare is the best owner to enable NMP's continued growth.

Innovations at RSNA 2024

GE HealthCare exhibited over 40 innovations at the Radiological Society of North America's (RSNA) 2024 Annual Meeting in Chicago. Workflow efficiency technologies like Clarify DL, an AI-powered bone-image reconstruction algorithm, enhance bone SPECT image quality and increase diagnostic confidence. Command Lite by IONIC Health enables radiology staff to focus on patient care while accessing remote collaboration and scan assistance.

In November, GE HealthCare announced the Pristina Via mammography system, designed to improve the screening experience for technologists and patients. It provides a suite of tools to balance diagnostic accuracy and fast-paced workflows for more patient-centered breast care.

GE HealthCare also announced additional clinical applications for the OEC 3D mobile CBCT C-arm portfolio to enable precise and effective imaging during endoscopic bronchoscopy procedures.